CoolPrep San
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Taejun Pharmaceutical Co., Ltd.
MFDS item code 201105080 · Approved 2011.08.05 · Insurance code 650102430
Preparation for examination by bowel cleansing before colonoscopy
This medication is used as a bowel cleansing agent to clean the intestines before undergoing a colon X-ray examination or endoscopy. It helps remove waste and residue inside the intestines, making accurate examination possible. Therefore, it facilitates smoother and more accurate procedures.
Adults aged 18 years and older: Take in divided doses or as a single dose as follows. (Product A (bottle pack), Product B (pouch pack)) Add 1 sachet of Product B to the 1L container containing Product A, add an appropriate amount of water to dissolve, then add more water to the 1L mark and shake well to prepare a uniform solution. The solution may be refrigerated before drinking, if needed. Store the prepared solution refrigerated and use within 24 hours. 1) Split-dose method: On the evening before colonoscopy, drink 1L of the prepared solution over 1 hour (one 250mL cup every 15 minutes), then drink 0.5L of water. The following morning, drink 1L of the prepared solution over 1 hour, then drink 0.5L of water. This process must be completed at least 1 hour before the start of colonoscopy. 2) Non-split dose (evening dose) method: At around 6 p.m. on the evening before colonoscopy, drink 1L of the prepared solution over 1 hour (one 250mL cup every 15 minutes), then, 1.5 hours later, drink 1L of the prepared solution over 1 hour. Also drink an additional 1L of water during the evening. (Product A (pouch pack), Product B (pouch pack)) [Preparation of 500mL solution] Place 1 sachet of Product A and 1 sachet of Product B in a container (500mL), dissolve in an appropriate amount of water, then add more water to the 500mL mark and shake well to prepare a uniform solution. Prepare a total of 4 batches of the prepared solution, 500mL each. The solution may be refrigerated before drinking, if needed. Store the prepared solution refrigerated and use within 24 hours. [Administration] 1) Split-dose method: On the evening before colonoscopy, drink 1L of the prepared solution (prepared as 2 batches of 500mL) over 1 hour (one 250mL cup every 15 minutes), and drink an additional 500mL of water. The following morning, drink 1L of the prepared solution (prepared as 2 batches of 500mL) over 1 hour, and drink an additional 500mL of water. This process must be completed at least 1 hour before the start of colonoscopy. 2) Non-split dose (evening) method: At around 6 p.m. on the evening before colonoscopy, drink 1L of the prepared solution (prepared as 2 batches of 500mL) over 1 hour (one 250mL cup every 15 minutes), then, 1.5 hours later, drink 1L of the prepared solution (prepared as 2 batches of 500mL) over 1 hour, followed by an additional 1L of water. Coolprep Powder should be dissolved in water and prepared as a solution, then a total of 2 liters should be taken. (Product A (pouch pack), Product B (pouch pack)) [Preparation of 250mL solution] Place 1 sachet of Product A and 1 sachet of Product B in a container (250mL), dissolve in an appropriate amount of water, then add more water to the 250mL mark and shake well to prepare a uniform solution. Prepare a total of 8 batches of the prepared solution, 250mL each. The solution may be refrigerated before drinking, if needed. Store the prepared solution refrigerated and use within 24 hours. [Administration] 1) Split-dose method: On the evening before colonoscopy, drink 1L of the prepared solution (prepared as 4 batches of 250mL) over 1 hour (one 250mL cup every 15 minutes), and drink an additional 500mL of water. The following morning, drink 1L of the prepared solution (prepared as 4 batches of 250mL) over 1 hour, and drink an additional 500mL of water. This process must be completed at least 1 hour before the start of colonoscopy. 2) Non-split dose (evening) method: At around 6 p.m. on the evening before colonoscopy, drink 1L of the prepared solution (prepared as 4 batches of 250mL) over 1 hour (one 250mL cup every 15 minutes), then, 1.5 hours later, drink 1L of the prepared solution (prepared as 4 batches of 250mL) over 1 hour, followed by an additional 1L of water. Coolprep Powder should be dissolved in water and prepared as a solution, then a total of 2 liters should be taken.
This medication may rarely induce generalized tonic-clonic seizures even in patients without a history of seizures, so caution is particularly advised in cases of electrolyte abnormalities. Patients using diuretics or ACE inhibitors that may cause electrolyte abnormalities or those suspected of having hyponatremia should be managed carefully. It is necessary to check sodium, potassium, calcium, and kidney function through blood tests before and after colonic endoscopy. This medication should not be used in patients with intestinal obstruction, gastrointestinal obstruction, perforation, toxic colitis, or toxic megacolon, and should be administered with caution in patients with severe ulcerative colitis. The artificial sweetener aspartame included in this medication breaks down into phenylalanine and should not be given to patients with phenylketonuria. Patients allergic to this medication or its ingredients, suspected of having gastrointestinal obstruction or perforation, severe dehydration, or heart failure should not be treated. In particular, there is no clinical experience in children (under 18 years old), so it should not be used. Patients with intestinal stricture or severe constipation, the elderly, frail patients, patients at high risk of pulmonary aspiration due to vomiting reflex disorders or altered consciousness should be treated with caution. This medication can cause metabolic imbalances such as hunger, hypophosphatemia, hypokalemia, as well as gastrointestinal symptoms like sleep disturbances, dizziness, headaches, abdominal pain, nausea, and abdominal distension. Serious side effects such as allergic reactions, gastric mucosal damage in the elderly, cardiac arrest, and acute pulmonary edema have also been reported. Patients' bowel movements should be monitored before administration, and appropriate bowel movements should be observed during treatment. Intestinal activity begins about 1 hour after administration. If severe abdominal distension or pain occurs at this time, medication should be adjusted or stopped and medical consultation sought. If symptoms of fluid or electrolyte imbalance occur, blood tests should be performed to assess the condition and appropriate treatment should be initiated. For patients at high risk of cardiac disease or electrolyte imbalances, it is advisable to perform an electrocardiogram before and after administration. This medication may cause diarrhea, so adequate fluid intake is necessary. It is advisable not to use it with irritant laxatives as it may increase the risk of mucosal ulcers or ischemic colitis. Before administration, patients should eat lightly, and solid food should not be consumed 1 hour before administration. The effects of this medication on driving or operating machinery are unknown. When taken with other medications, it may affect absorption, so it is advisable to space out the timing of other drug intakes. Pregnant or breastfeeding women should use this medication with caution based on a physician's judgment as its safety has not been established. Caution is required for potential dehydration and electrolyte abnormalities due to overdose, and careful monitoring and appropriate treatment should be initiated if necessary. Prepared solutions should be consumed immediately, and any unused remaining solutions should be discarded within 24 hours, stored out of the reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to prolong the medication's efficacy.
1) Preparation A: A white or yellowish powder in an aluminum foil pouch with a lemon flavor. 2) Preparation B: A white crystal or crystalline powder in an aluminum foil pouch that is odorless and sour tasting.
Preparation A: 1 pouch (56.402g) x 4 pouches / carton, Preparation B: 1 pouch (5.3g) x 4 pouches / carton
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Taejun Pharmaceutical Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Hanook Pharma Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Albozen Korea Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Korea Pavis Pharmaceutical Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Huons Co., Ltd.
Sodium Chloride 1.3455g · Potassium Chloride 0.5075g +4 more
Prescription medication · Combination
Highple Biomedical Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
IntroBioPharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.